These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 34314294

  • 1. Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.
    Han W, Jin Y, Xu M, Zhao SS, Shi Q, Qu X, Zhang R, Li J, Wu Y, Chen L.
    Hematology; 2021 Dec; 26(1):510-517. PubMed ID: 34314294
    [Abstract] [Full Text] [Related]

  • 2. R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study.
    Chu B, Wang YT, Gao S, Shi L, Lu MQ, Fang LJ, Xiang QQ, Chen Y, Wang MZ, Wang LF, Sun K, Yang J, Duan F, Bao L.
    Ann Hematol; 2024 Sep; 103(9):3677-3690. PubMed ID: 38955826
    [Abstract] [Full Text] [Related]

  • 3. The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
    Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, Falcioni S, Picardi P, Mazzotta S, Troiani E, Dalsass A, Mestichelli F, Angelini M, Camaioni E, Maravalle D, Angelini S, Pezzoni V.
    Br J Haematol; 2021 May; 193(3):542-550. PubMed ID: 33792026
    [Abstract] [Full Text] [Related]

  • 4. Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.
    Li Q, Ai L, Zuo L, Li J, Zhao F, Xu A, Zhang B, Cai L, Hu Y, Sun C.
    Ann Med; 2024 Dec; 56(1):2338604. PubMed ID: 38599340
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma.
    Abe Y, Narita K, Kobayashi H, Kitadate A, Miura D, Takeuchi M, O'uchi E, O'uchi T, Matsue K.
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
    [Abstract] [Full Text] [Related]

  • 6. Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.
    Chakraborty R, Muchtar E, Kumar SK, Jevremovic D, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA.
    Haematologica; 2017 Aug; 102(8):1439-1445. PubMed ID: 28473618
    [Abstract] [Full Text] [Related]

  • 7. Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
    Gonsalves WI, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui MA, Kyle RA, Gertz MA, Rajkumar SV, Kumar SK.
    Am J Hematol; 2020 Mar; 95(3):310-315. PubMed ID: 31867775
    [Abstract] [Full Text] [Related]

  • 8. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
    Li F, Gao YJ, Li SS, Xi YY, Yang XW, Su YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
    [Abstract] [Full Text] [Related]

  • 9. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
    Sanoja-Flores L, Flores-Montero J, Garcés JJ, Paiva B, Puig N, García-Mateo A, García-Sánchez O, Corral-Mateos A, Burgos L, Blanco E, Hernández-Martín J, Pontes R, Díez-Campelo M, Millacoy P, Rodríguez-Otero P, Prosper F, Merino J, Vidriales MB, García-Sanz R, Romero A, Palomera L, Ríos-Tamayo R, Pérez-Andrés M, Blanco JF, González M, van Dongen JJM, Durie B, Mateos MV, San-Miguel J, Orfao A, EuroFlow consortium.
    Blood Cancer J; 2018 Nov 19; 8(12):117. PubMed ID: 30455467
    [Abstract] [Full Text] [Related]

  • 10. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy.
    Sanoja-Flores L, Flores-Montero J, Puig N, Contreras-Sanfeliciano T, Pontes R, Corral-Mateos A, García-Sánchez O, Díez-Campelo M, Pessoa de Magalhães RJ, García-Martín L, Alonso-Alonso JM, García-Mateo A, Aguilar-Franco C, Labrador J, Barez-García A, Maiolino A, Paiva B, San Miguel J, Sobral da Costa E, González M, Mateos MV, Durie B, van Dongen JJM, Orfao A.
    Blood; 2019 Dec 12; 134(24):2218-2222. PubMed ID: 31697808
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma.
    Kastritis E, Terpos E, Roussou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E, Fotiou D, Ziogas D, Panagiotidis I, Kafantari E, Giannouli S, Zomas A, Konstantopoulos K, Dimopoulos MA.
    Haematologica; 2017 Mar 12; 102(3):593-599. PubMed ID: 27789676
    [Abstract] [Full Text] [Related]

  • 12. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.
    Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T, Bringhen S, Gay F, Attal M, Passera R, Spencer A, Offidani M, Kumar S, Musto P, Lonial S, Petrucci MT, Orlowski RZ, Zamagni E, Morgan G, Dimopoulos MA, Durie BG, Anderson KC, Sonneveld P, San Miguel J, Cavo M, Rajkumar SV, Moreau P.
    J Clin Oncol; 2015 Sep 10; 33(26):2863-9. PubMed ID: 26240224
    [Abstract] [Full Text] [Related]

  • 13. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
    Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Schroeder MA, Tomasson M, Wildes TM, Vij R.
    Clin Lymphoma Myeloma Leuk; 2019 May 10; 19(5):285-289. PubMed ID: 30792096
    [Abstract] [Full Text] [Related]

  • 14. Plasma cell maturity as a predictor of prognosis in multiple myeloma.
    Iriyama N, Miura K, Hatta Y, Uchino Y, Kurita D, Takahashi H, Sakagami H, Sakagami M, Kobayashi Y, Nakagawa M, Ohtake S, Iizuka Y, Takei M.
    Med Oncol; 2016 Aug 10; 33(8):87. PubMed ID: 27383407
    [Abstract] [Full Text] [Related]

  • 15. Natural history of multiple myeloma with de novo del(17p).
    Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK.
    Blood Cancer J; 2019 Mar 07; 9(3):32. PubMed ID: 30846679
    [Abstract] [Full Text] [Related]

  • 16. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
    Bila J, Jelicic J, Dencic Fekete M, Trajkovic G, Sretenovic A, Perunicic Jovanovic M, Antic D, Mihaljevic B.
    Oncol Res Treat; 2017 Mar 07; 40(10):616-620. PubMed ID: 28950269
    [Abstract] [Full Text] [Related]

  • 17. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
    Du J, Lu J, Gao W, Liu J, He H, Li L, Li R, Zhou L, Jiang H, Chen W, Fu W, Hou J.
    Ann Hematol; 2020 Aug 07; 99(8):1779-1791. PubMed ID: 32594218
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation.
    Çiftçiler R, Göker H, Demiroğlu H, Haznedaroğlu İC, Sayınalp N, Aksu S, Özcebe O, Büyükaşık Y.
    Turk J Haematol; 2021 Feb 25; 38(1):33-40. PubMed ID: 32539315
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
    González-Calle V, Slack A, Keane N, Luft S, Pearce KE, Ketterling RP, Jain T, Chirackal S, Reeder C, Mikhael J, Noel P, Mayo A, Adams RH, Ahmann G, Braggio E, Stewart AK, Bergsagel PL, Van Wier SA, Fonseca R.
    Ann Hematol; 2018 Aug 25; 97(8):1453-1462. PubMed ID: 29623394
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
    van Beers EH, van Vliet MH, Kuiper R, de Best L, Anderson KC, Chari A, Jagannath S, Jakubowiak A, Kumar SK, Levy JB, Auclair D, Lonial S, Reece D, Richardson P, Siegel DS, Stewart AK, Trudel S, Vij R, Zimmerman TM, Fonseca R.
    Clin Lymphoma Myeloma Leuk; 2017 Sep 25; 17(9):555-562. PubMed ID: 28735890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.